Related Experiment Video
Updated: Oct 23, 2025
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
Intravascular Large B-Cell Lymphoma: A Diagnostic Dilemma
Arya Mariam Roy1, Yadav Pandey2, Derek Middleton2
1Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, USA.
Intravascular large B-cell lymphoma (ILBCL) is a rare cancer where lymphoma cells grow inside blood vessels. Early diagnosis is critical due to its aggressive nature and high mortality, often missed due to atypical symptoms.
Area of Science:
- Hematology
- Oncology
- Rare Diseases
Background:
- Intravascular large B-cell lymphoma (ILBCL) is a rare hematologic malignancy.
- Characterized by lymphoma cells confined to the lumen of blood vessels.
- Annual incidence is less than 0.5 per 1,000,000, typically affecting individuals around 70 years old.
Observation:
- Diagnosis is challenging due to lack of peripheral smear involvement and lymphadenopathy.
- Commonly affects the central nervous system and skin, but can involve any organ system.
- Presents with constitutional symptoms and fever of unknown origin, often with atypical manifestations.
Findings:
- Two cases of ILBCL are presented, highlighting diagnostic difficulties.
- One patient was diagnosed posthumously, underscoring delayed diagnosis issues.
- The disease is aggressive, with delayed diagnosis leading to fatal outcomes.
Implications:
- High clinical suspicion is essential for prompt ILBCL diagnosis.
- Early detection and treatment initiation are crucial for improving patient outcomes.
- Further research into diagnostic markers and treatment strategies for ILBCL is warranted.
More Related Videos
06:20Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor
Published on: January 12, 2024
15:07VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015